Health-Related Quality of Life: Healthy Days Symptoms

Abstract

The Health-Related Quality of Life: Healthy Days Symptoms module is a standardized, five-item population health surveillance instrument developed by the Centers for Disease Control and Prevention (CDC) as an expansion of the core CDC HRQOL-4 (Healthy Days Core Module). Designed to quantify secondary and distinct dimensions of subjective somatic and emotional burden, this module captures specific symptom manifestations over a continuous 30-day retrospective recall window. The instrument assesses five discrete symptom domains: (1) pain-related activity restriction, (2) depressive affect, (3) anxiety and psychological tension, (4) sleep insufficiency or insomnia, and (5) positive vitality or energetic state. Unlike conventional ordinal Likert-type scales, the Healthy Days Symptoms module employs a time-based metric where respondents report the absolute number of days (from 0 to 30) during which each symptom was experienced. This design yields intuitive, continuous summary indicators that reflect temporal symptom density, facilitating both cross-sectional surveillance and longitudinal public health tracking.

Psychometric evaluations conducted across large-scale population surveys—most notably within the Behavioral Risk Factor Surveillance System (BRFSS) and the National Health and Nutrition Examination Survey (NHANES)—demonstrate moderate to strong test-retest reliability (intraclass correlation coefficients ranging from 0.60 to 0.82 across diverse time intervals), robust construct validity, and significant criterion validity. The symptom items exhibit predictable patterns of association with established generic health profiles (such as the Medical Outcomes Study 36-Item Short Form Survey, SF-36, and the EuroQol EQ-5D), clinical psychiatric scales, and objective morbidity indices. With its low respondent burden, open-access public domain status, and clear mathematical framework for deriving “healthy days” versus “symptom-burdened days,” the Healthy Days Symptoms module serves as an essential measurement paradigm for public health researchers, epidemiologists, health economists, and behavioral scientists evaluating population well-being and health disparities.

Keywords

Health-Related Quality of Life, CDC HRQOL, Healthy Days Symptoms Module, BRFSS, Population Health Surveillance, Pain Impairment, Depressive Symptoms, Anxiety Symptoms, Sleep Insufficiency, Vitality, Psychometrics, Epidemiology

Authors

The Healthy Days Symptoms module was developed by the Health Care and Aging Studies Branch within the Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, United States.

Key psychometricians, epidemiologists, and behavioral scientists leading the operationalization, psychometric validation, and longitudinal surveillance of the Healthy Days measures include:

• David G. Moriarty — Epidemiologist and lead investigator for the CDC Health-Related Quality of Life Surveillance Program, Atlanta, GA.
• Matthew M. Zack, MD, MPH — Medical Epidemiologist, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.
• Rosemarie Kobau, MPH, MAPP — Public Health Scientist and Senior Health Methodologist, CDC HRQOL Program.
• Vincent J. Giles, MPH — Public Health Analyst and Project Statistician, CDC HRQOL Program.

Institutional contact information and programmatic documentation are archived by the Centers for Disease Control and Prevention, Division of Population Health, 4770 Buford Hwy NE, Atlanta, GA 30341, USA (Official CDC HRQOL Program: https://www.cdc.gov/hrqol/).

Purpose

The primary purpose of the Health-Related Quality of Life: Healthy Days Symptoms module is to assess the multidimensional symptom burden experienced by individuals within communities and clinical populations over a 30-day temporal baseline. Developed during the 1990s as public health shifted from exclusively monitoring mortality, morbidity, and infectious disease toward tracking functional capacity, subjective well-being, and chronic condition burden, the Healthy Days framework provides a sensitive, low-burden metric for population health monitoring.

While the four-item core module (CDC HRQOL-4) captures general self-rated health, physically unhealthy days, mentally unhealthy days, and activity limitation days, public health authorities recognized that broad somatic and psychiatric labels aggregate heterogeneous states. The Healthy Days Symptoms module was specifically operationalized to provide granular symptom resolution by disaggregating physical and mental impairment into four core pathological domains (pain-related functional limitation, depressive affect, anxiety-related arousal, and sleep disruption) alongside one positive salutogenic indicator (perceived physical energy and vitality).

In clinical and epidemiological research, this module accomplishes several strategic objectives:

• Population Health Surveillance: Benchmarking the prevalence and temporal density of acute and chronic symptoms across geographic regions, sociodemographic strata, and vulnerable subpopulations.
• Tracking National Health Goals: Generating empirical indicators to evaluate initiatives such as the United States Department of Health and Human Services (HHS) Healthy People objectives (Healthy People 2020 / 2030), tracking the elimination of health disparities.
• Health Services and Economic Evaluation: Providing continuous quantitative units (days per month) that translate directly into health-state utility equivalents, disability-adjusted time intervals, productivity loss calculations, and cost-effectiveness analyses.
• Clinical Trial and Community Intervention Monitoring: Serving as a responsive, patient-reported outcome measure (PROM) capable of detecting clinically meaningful shifts in daily symptom burden resulting from behavioral, pharmacological, or public health interventions.

By measuring symptoms in units of time (days out of the past 30) rather than subjective abstract intensity ratings (such as “mild,” “moderate,” or “severe”), the instrument minimizes cognitive ambiguity, improves cross-cultural comparability, and provides actionable data readily interpreted by policy makers, clinicians, and the lay public.

Psychological Construct

The Healthy Days Symptoms module evaluates Health-Related Quality of Life (HRQOL), defined by the World Health Organization and the CDC as an individual’s or group’s perceived physical and mental health over time. Rather than measuring single underlying unidimensional traits, the Symptoms module is conceptualized as an aggregate multi-indicator profile reflecting the biopsychosocial disruption of daily life. The scale operationalizes five distinct symptom constructs:

1. Pain-Related Functional Impairment

Evaluated through the item assessing how many days pain made it difficult to conduct usual activities (such as self-care, employment, or recreation). This construct does not measure sensory nociceptive intensity in isolation; rather, it operationalizes pain through the prism of behavioral and functional disability. Rooted in the International Classification of Functioning, Disability and Health (ICF), it quantifies the degree to which acute or chronic musculoskeletal, neuropathic, or somatic pain prevents the execution of routine life roles and occupational duties.

2. Depressed Affect and Dysphoria

Captured by querying the number of days the individual felt “sad, blue, or depressed.” This construct reflects subjective internalizing emotional distress, low mood, anhedonia, and affective demoralization. In psychiatric epidemiology, this item serves as a sensitive population-level marker for subthreshold and major depressive syndromes as delineated within the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), reflecting the temporal frequency of dysphoric mood states over a one-month epoch.

3. Anxious Arousal and Psychological Tension

Assessed via the frequency of feeling “worried, tense, or anxious.” This construct measures cognitive and physiological dimensions of anxiety, encompassing generalized worry, somatic tension, apprehension, and autonomic hyperarousal. By focusing on worry and tension, it captures emotional dysregulation common across Generalized Anxiety Disorder, panic spectrum conditions, and environmental stress responses.

4. Subjective Sleep Insufficiency and Rest Deficit

Operationalized through the item measuring days without adequate rest or sleep. This dimension reflects perceived sleep debt, sleep-maintenance disruptions, early-morning awakenings, and unrefreshing sleep (insomnia symptoms). In behavioral medicine, subjective sleep deficit is recognized as a profound physiological stressor that impairs cognitive executive functioning, immune homeostasis, and metabolic regulation, serving as a critical bidirectional bridge between physical and mental morbidity.

5. Positive Energetic Arousal and Perceived Vitality

Reflected in the item assessing days the respondent felt “very healthy and full of energy.” In contrast to the preceding four deficit-oriented constructs, this item captures positive physical functioning, resilience, and vitality (akin to the subjective vitality construct articulated in self-determination theory and positive psychology). It emphasizes that health is not merely the absence of disease or infirmity, but the active presence of vigor, energy, and robust physiological resilience.

Theoretical Framework

The theoretical architecture of the Healthy Days Symptoms module is anchored in the Biopsychosocial Model of Health (Engel, 1977) and Wilson and Cleary’s Conceptual Model of Patient Outcomes (1995). Wilson and Cleary proposed a hierarchical taxonomy linking five distinct levels of health concepts: (1) biological and physiological factors, (2) symptom status, (3) functioning, (4) general health perceptions, and (5) overall quality of life.

Within this theoretical model, the Healthy Days Symptoms module operates precisely at the interface between symptom status and functional status. Biological anomalies (e.g., osteoarthritis, chronic neurochemical imbalances, cardiopulmonary pathology) produce subjective symptoms (pain, dysphoria, nervous tension, fatigue). These symptoms, in turn, directly govern an individual’s behavioral capacity to execute essential biological, social, and economic roles. By evaluating how frequently symptoms intrude upon conscious awareness and daily living, the module captures the direct phenomenological translation of biological vulnerability into functional health decrement.

Furthermore, the instrument incorporates modern Time-Budget and Cognitive Recall Paradigms in survey methodology. Standard categorical psychometric response formats (e.g., Likert scales ranging from “strongly disagree” to “strongly agree”) are frequently compromised by idiosyncratic response styles, cognitive anchoring discrepancies, and cross-cultural semantic drift. In contrast, the CDC’s operationalization relies on an anchored time-budgeting heuristic: respondents are asked to recall the occurrence of a given state within an unambiguous, ecologically salient 30-day temporal container. This design assumes that time is a universal, non-arbitrary currency through which individuals assess the personal impact of health conditions, substantially reducing cognitive bias and linguistic translation distortion.

Validity

The psychometric validity of the CDC Healthy Days measures, including the Symptoms Module, has been extensively documented in population-based, clinical, and community validation studies involving hundreds of thousands of participants:

Construct and Convergent Validity

Convergent validity has been evaluated by benchmarking the symptom items against established, comprehensive psychometric inventories. In large comparative validation studies (e.g., Andresen et al., 2003; Moriarty et al., 2003), individual items in the Symptoms module showed robust, statistically significant correlations with corresponding domains of the Medical Outcomes Study SF-36:

• The Pain Activity Restriction item correlates strongly with the SF-36 Bodily Pain subscale (Pearson’s $r = -0.68$ to $-0.74$) and the Physical Functioning subscale ($r = -0.55$).
• The Depressive Affect and Anxiety/Tension items exhibit high convergence with the SF-36 Mental Health Inventory (MHI-5) subscale ($r = -0.65$ to $-0.71$) and correlate strongly with clinical screeners such as the Patient Health Questionnaire-9 (PHQ-9, $r = 0.67$) and Generalized Anxiety Disorder-7 (GAD-7, $r = 0.64$).
• The Sleep Insufficiency item demonstrates significant convergence with the Pittsburgh Sleep Quality Index (PSQI) total score ($r = 0.58$).
• The Vitality/Energy item demonstrates high positive correlation with the SF-36 Vitality subscale ($r = 0.72$).

Discriminant and Known-Groups Validity

The Healthy Days Symptoms module exhibits exceptional known-groups discriminant validity across diverse demographic and clinical populations. Epidemiological analyses from the BRFSS indicate that individuals diagnosed with chronic medical conditions (e.g., rheumatoid arthritis, fibromyalgia, multiple sclerosis, coronary heart disease) report significantly higher pain-burdened days (mean $>12.4$ days) compared to healthy controls (mean $<2.1$ days, $p < 0.001$). Similarly, psychiatric cohorts with documented major affective disorders report drastically elevated depressive and anxious days (frequently exceeding 20 days per month) relative to the non-clinical general population.

Criterion and Predictive Validity

Longitudinal studies utilizing BRFSS cohorts linked to administrative mortality and hospitalization records establish the module’s prospective predictive validity. A high frequency of symptom days (particularly sleep deficit and depressive affect) prospectively predicts elevated rates of emergency department visits, general medical hospitalizations, workplace absenteeism, short-term disability claims, and all-cause mortality, independent of baseline clinical diagnoses, age, and socioeconomic status.

Reliability

The empirical assessment of reliability for count-based temporal survey items presents unique methodological challenges, as subjective symptom fluctuations across time reflect genuine physiological or psychological change rather than pure measurement error. Nonetheless, classic test-retest investigations and internal consistency evaluations have confirmed the module’s psychometric stability:

Test-Retest Reliability

Test-retest reliability has been rigorously examined across multiple intervals ranging from 2 days to 30 days. In a landmark methodological study conducted by Andresen and colleagues (2003), the Healthy Days items demonstrated substantial stability when administered over a 2- to 3-week interval:

• Pain Impairment: Intraclass Correlation Coefficient ($ ext{ICC}$) =$0.73$ to $0.78$; Spearman rank-order correlation ($r_s$) = $0.75$.
• Depressive Affect: $ ext{ICC} = 0.65$ to $0.72$; $r_s = 0.70$.
• Anxiety and Tension: $ ext{ICC} = 0.63$ to $0.69$; $r_s = 0.67$.
• Sleep Insufficiency: $ ext{ICC} = 0.68$ to $0.74$; $r_s = 0.71$.
• Vitality and Energy: $ ext{ICC} = 0.60$ to $0.68$; $r_s = 0.64$.

Weighted Cohen’s kappa ($\kappa_w$) statistics for categorical agreement across stratified symptom day groupings (e.g., 0 days, 1–13 days, 14+ days) range from $0.58$ to $0.75$, denoting moderate to substantial concordance across repeated administrations in stable populations.

Internal Consistency and Scale Intercorrelations

Because the Symptoms module is conceptualized as an aggregate profile of semi-independent somatic and affective dimensions rather than a strictly unidimensional reflective construct, traditional internal consistency metrics like Cronbach’s alpha are theoretically secondary. Nonetheless, when composite distress scores are computed across the four negative symptom items (Pain, Depression, Anxiety, Sleep), the internal consistency remains sound, with Cronbach’s alpha coefficients routinely ranging between $lpha = 0.76$ and $lpha = 0.84$. McDonald’s omega total ($\omega_t$) typically exceeds $0.80$, reflecting solid structural coherence among negative symptom manifestations.

Factor Analysis

Structural evaluations of the Healthy Days measures through both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) confirm the multidimensional nature of the instrument while validating its latent alignment with broader physical and mental health dimensions.

Exploratory Factor Structure

When factor-analyzed alongside the core CDC HRQOL-4 items using principal axis factoring or maximum likelihood estimation with oblique rotation (e.g., Promax or Oblimin), the five symptom items consistently resolve into two distinct but moderately correlated latent factors ($\phi pprox 0.45 ext{–}0.55$), corresponding to Physical Health / Somatic Impairment and Mental-Emotional Health / Affective Distress:

• Factor 1: Mental/Affective Health Burden: Characterized by high, salient factor loadings on Depressed Affect ($\lambda = 0.82 ext{–}0.88$) and Anxious Tension ($\lambda = 0.78 ext{–}0.84$), with moderate secondary loading on Sleep Insufficiency ($\lambda = 0.48 ext{–}0.56$).
• Factor 2: Physical/Somatic Impairment: Characterized by dominant loadings from Pain-Related Activity Restriction ($\lambda = 0.74 ext{–}0.81$), with Perceived Vitality and Energy exhibiting an inverse loading onto this dimension ($\lambda = -0.52 ext{–}-0.61$) or cross-loading moderately onto mental well-being.

Confirmatory Factor Analysis (CFA) and Measurement Invariance

Structural equation modeling confirms that a two-factor correlated model or a bifactor specification (incorporating a general “Global Symptom Burden” factor alongside orthogonal somatic and psychological group factors) demonstrates superior model fit compared to a single-factor unidimensional solution across large epidemiological samples:

• Comparative Fit Index ($ ext{CFI}$)$> 0.96$
• Tucker-Lewis Index ($ ext{TLI}$)$> 0.95$
• Root Mean Square Error of Approximation ($ ext{RMSEA}$)$< 0.05$ ($90%\text{ CI: } [0.042, 0.058]$)
• Standardized Root Mean Square Residual ($ ext{SRMR}$)$< 0.035$

Multi-group CFA has further established robust measurement invariance (configural, metric, and scalar invariance) across sexes, age groups (young adults, middle-aged adults, and older adults), and major racial/ethnic demographics, verifying that the scale items measure equivalent underlying constructs with consistent measurement precision across heterogeneous populations.

Instrument / Measurement Tool

Technical Characteristics

• Instrument Type: Standardized Patient-Reported Outcome Measure (PROM) / Epidemiological Health Surveillance Module.
• Target Population: General adult population (aged 18 and older); also validated for adolescent populations (aged 12–17) in modified school-based survey formats.
• Administration Format: Self-administered (paper-and-pencil, computer-assisted web interview [CAWI]) or interviewer-administered (computer-assisted telephone interview [CATI], face-to-face).
• Item Count: 5 primary continuous-count questions.
• Recall Period: Past 30 consecutive days.
• Average Completion Time: 1 to 2 minutes.
• Response Format: Open continuous numerical entry ranging from 0 to 30 days (integers).

Scoring Principles and Algorithms

The Healthy Days Symptoms module can be analyzed as individual symptom metrics or integrated into composite “Healthy Days” indicators. The standard scoring rules operationalized by the CDC are defined as follows:

• Negative Symptom Items (Items 1 to 4): For Pain, Depression, Anxiety, and Sleep Insufficiency, respondents report the absolute number of days the impairment was present ($0 le \text{Days} le 30$). To convert these into symptom-free “Healthy Days” equivalents, subtract the reported number of unhealthy days from 30:
  • $\text{Pain-Free Healthy Days} = 30 – \text{reported days of pain}$
  • $\text{Depression-Free Healthy Days} = 30 – \text{reported days sad/blue/depressed}$
  • $\text{Anxiety-Free Healthy Days} = 30 – \text{reported days worried/tense/anxious}$
  • $\text{Adequate Sleep Healthy Days} = 30 – \text{reported days lacking rest/sleep}$
• Positive Vitality Item (Item 5): For perceived energy and health, the item reflects positive well-being directly. Therefore, healthy days equal the exact number of days reported:
  • $\text{Vitality Healthy Days} = \text{reported days felt healthy and full of energy}$
• Epidemiological Cut-Points: In public health surveillance, individuals reporting $ge 14$ unhealthy days for any given symptom within the 30-day window are clinically categorized as experiencing “frequent symptom impairment” (e.g., Frequent Pain, Frequent Mental Distress, Frequent Sleep Disturbance), aligning with clinical criteria indicating chronic or disabling impairment.

Permissions & Fee and Test Year

The Health-Related Quality of Life: Healthy Days Symptoms module was developed by federal employees of the United States Government under the auspices of the Centers for Disease Control and Prevention (CDC) and was formally operationalized in population surveillance during the 1990s, with foundational reference manuals and standardization compendia published in 2000.

As a work of the United States Government, the Healthy Days Symptoms module is in the public domain. There are no licensing fees, copyright royalties, or proprietary software restrictions associated with its use. Researchers, healthcare institutions, public health departments, and commercial entities are free to administer, reproduce, adapt, and translate the instrument without formal prior permission from the CDC. The CDC requests that authors cite the foundational agency documentation and methodological publications when publishing empirical investigations that employ the scale.

References

• Andresen, E. M., Catlin, T. K., Wyrwich, K. W., & Jackson-Thompson, J. (2003). Retest reliability for Healthy Days core questions. Journal of Health and Quality of Life Outcomes, 1(1), 63. https://doi.org/10.1186/1477-7525-1-63
• Centers for Disease Control and Prevention. (2000). Measuring healthy days: Population assessment of health-related quality of life. Atlanta, GA: U.S. Department of Health and Human Services, CDC. https://www.cdc.gov/hrqol/pdfs/mhd.pdf
• Cintron, Y., & Kobau, R. (2000). Health-related quality of life—Puerto Rico, 1996–2000. Morbidity and Mortality Weekly Report (MMWR), 51(8), 166–168. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5108a3.htm
• Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460
• Hennessy, C. H., Moriarty, D. G., Zack, M. M., Scherr, P. A., & Brackbill, R. (1994). Measuring health-related quality of life for public health surveillance. Public Health Reports, 109(5), 665–672.
• Kobau, R., Safran, M. A., Zack, M. M., Moriarty, D. G., & Giles, W. (2004). Sad, blue, or depressed days, health behaviors and health-related quality of life, Behavioral Risk Factor Surveillance System, 2001. Health and Quality of Life Outcomes, 2, 40. https://doi.org/10.1186/1477-7525-2-40
• Moriarty, D. G., Zack, M. M., & Kobau, R. (2003). The Centers for Disease Control and Prevention’s Healthy Days Measures—Population tracking of health-related quality of life. Health and Quality of Life Outcomes, 1, 37. https://doi.org/10.1186/1477-7525-1-37
• Newschaffer, C. J. (1998). Validation of Behavioral Risk Factor Surveillance System (BRFSS) HRQOL measures in a statewide sample. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention.
• Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483. https://doi.org/10.1097/00005650-199206000-00002
• Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. JAMA, 273(1), 59–65. https://doi.org/10.1001/jama.1995.03520250075037
• Zack, M. M., Moriarty, D. G., Stroup, D. F., & Giles, W. H. (2004). Trends in health-related quality of life—United States, 1993–2002. Morbidity and Mortality Weekly Report (MMWR), 53(24), 530–534.

13. Items of the Scale (Questionnaire)